Oxycodone-induced dopaminergic and respiratory effects are modulated by deep brain stimulation

Area of Science:

• Neuroscience
• Addiction Research
• Neuromodulation

Background:

• Opioid overdose deaths are a major public health crisis in the US.
• Deep brain stimulation (DBS) is an emerging therapeutic approach for substance use disorders.
• The ventral tegmental area (VTA) plays a critical role in reward pathways and addiction.

Purpose of the Study:

• To investigate the effects of VTA DBS on oxycodone-induced changes in dopamine levels and respiration.
• To test the hypothesis that VTA DBS modulates both dopaminergic and respiratory effects of oxycodone.

Main Methods:

• Utilized multiple-cyclic square wave voltammetry (M-CSWV) in urethane-anesthetized rats.
• Administered oxycodone (2.5 mg/kg, i.v.) and recorded dopamine levels in the nucleus accumbens core (NAcc).
• Applied continuous DBS (130 Hz, 0.2 ms, 0.2 mA) to the VTA and monitored respiratory rate.

Main Results:

• Oxycodone administration significantly increased NAcc dopamine levels and decreased respiratory rate.
• VTA DBS reduced baseline dopamine levels and attenuated the oxycodone-induced dopamine surge.
• VTA DBS also appeared to reverse the respiratory depression caused by oxycodone.

Conclusions:

• Ventral tegmental area deep brain stimulation demonstrates potential in alleviating key neurochemical and physiological effects of oxycodone.
• These findings support the use of neuromodulation technologies, specifically VTA DBS, as a novel treatment strategy for opioid addiction.